Abstract
Maintenance treatment in schizophrenia requires the integration of both medication and psychosocial treatment interventions for maximum effect. We review the recent evidence for strategies drawn from both domains. For the use of anti-psychotic medication we focus on studies of dose reduction using two strategies that differ in assumptions regarding the action of medication. They are: continuous low-dose and targeted, early intervention or intermittent treatment. For psychosocial interventions we focus on studies of family treatment. Regarding dose reduction, we conclude that both strategies are feasible but the targeted strategy incurs higher relapse and rehospitalization rates. Regarding family treatment, we conclude that family treatment provides benefits beyond other psychosocial interventions or usual care, but that there is no evidence for differences in efficacy among family treatments.
Similar content being viewed by others
References
Kane J, Schooler NR, Marder SR, Simpson GM, Casey DE: Methods for clinical evaluation of pharmacologic treatments of schizophrenia. In:Clinical Evaluation of Psychotropic Drugs (Prien RF, Robinson DS, Eds.) New York: Raven Press, 1994, pp. 345–372.
Davis JM: Overview: Maintenance therapy in psychiatry. I. Schizophrenia.Am J Psychiatry, 132:1237–1245, 1975.
Schooler NR: Maintenance medication for schizophrenia: strategies for dose reduction.Schizophr Bull, 17:311–324, 1991.
Kane JM, Marder SR: Psychopharmacologic treatment of schizophrenia.Schizophr Bull, 19:287–302, 1993.
Goldstein MJ, Rodnick EH, Evans JR, May PRA, Steinberg MR: Drug and family therapy in the aftercare of acute schizophrenics.Arch Gen Psychiatry, 35:11679–1177, 1978.
Kane JM, Rifkin A, Woerner M, Reardon G, Sarantakos S, Schiebel D, Ramos-Lorenzi J: Low-dose neuroleptic treatment of outpatient schizophrenics.Arch Gen Psychiatry, 40:893–896, 1983.
Kane JM, Rifkin A, Woerner M, Reardon G, Kreisman D, Blumenthal R, Borenstein M: High dose vs. low dose strategies in the treatment of schizophrenia.Psychopharm Bull, 21:533–537, 1985.
Kane JM, Woerner M, Sarantakos S: Depot neuroleptics: A comparative review of standard, intermediate, and low dose regimens.J Clin Psychiatry, 47(Suppl.):30–33, 1986.
Marder SR, Van Putten T, Mintz J, McKenzie J, Lebell M, Faltico G, May PRA: Costs and benefits of two doses of fluphenazine.Arch Gen Psychiatry, 41:1025–1029 1984.
Marder SR, Van Putten T, Mintz J, Lebell M, McKenzie J, May PRA: Low and conventional dose maintenance therapy with fluphenazine decanoate: Two year outcome.Arch Gen Psychiatry, 44:518–521 1987.
Johnson DAW, Ludlow JM, Street K, Taylor RDW: Double-blind comparison of half-dose and standard flupenthixol decanoate in the maintenance treatment of stabilized out-patients with schizophrenia.Br J Psych, 151:634–638, 1987.
Hogarty GE, McEvoy JP, Munetz M, DiBarry AL, Bartone P, Cather R, Cooley SJ, Ulrich RJ, Carter M, Madonia JM, Environmental/Personal Indicators in the Course of Schizophrenia Research Group: Dose of fluphenazine, familial expressed emotion, and outcome in schizophrenia.Arch Gen Psych, 45:797–80, 1988.
Kane JM, Davis JM, Schooler NR, Marder SR, Brauzer B, Casey DE: A one-year comparison of four dosages of haloperidol decanoate.Schizoph Res, 9:239–240, 1993.
Herz MI, Szymanski HV, Simon JC: Intermittent medication for stable schizophrenic outpatients: an alternative to maintenance medication.Am J Psychiatry, 139:918–922 1982.
Herz MI, Glazer WM, Mostert MA, Sheard MH, Szymanski HV, Hafez H, Mirza M, Vaha J: Intermittent vs. maintenance medication in schizophrenia.Arch Gen Psych, 48:333–339, 1991.
Carpenter WT, Jr., Hanlon TE, Heinrichs DW, Kirkpatrick B, Levine J, Buchanan RW: Continuous vs. targeted medication in schizophrenic outpatients: Outcome results.Am J Psychiatry, 147:1138–1148, 1990.
Jolley AG, Hirsch SR, McRink A, Manchanda R: Trial of brief intermittent prophylaxis for selected schizophrenic outpatients: Clinical outcome at one year.Br Med J, 298:985–990, 1989.
Jolley AG, Hirsch SR, Morrison E, McRink A: Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenic outpatients—Clinical and social outcome at two years.Br Med J, 301:837–842, 1990.
Pietzcker A, Gaebel W, Kopcke W: A German multi-center study on the neuroleptic long-term therapy of schizophrenic patients' preliminary report.Pharmacopsychiatry, 19:161–166, 1986.
Pietzcker A, Gaebel W, Kopcke W, et al: Intermittent versus maintenance neuroleptic long-term treatment in schizophrenia—2 year results of a German multicenter study.J Psychiat Res, 27:321–339, 1993.
Keith SJ, Schooler NR: Psychosocial and psychotherapeutic strategies for long-term treatment of schizophrenia. In:International Review of Psychiatry (Costa e Silva JA, Nadelson CC, eds.). American Psychiatric Press, Inc., Washington, DC, 1993, pp. 229–262.
Bellack AS, Mueser KT: Psychosocial treatment for schizophrenia.Schizophr Res, 19:317–336, 1993.
Johnson, D.: The Family's Experience of Living with Mental Illness. In: (Lefley H, Johnson D eds),Families as Allies in Treatment of the Mentally Ill; New Directions for Mental Health Professionals. American Psychiatric Press, Inc., Washington, DC 1990, pp. 31–63.
Lefley HP, Johnson DL (eds):Families as Allies in Treatment of the Mentally Ill: New Directions for Mental Health Professionals. Washington, DC: American Psychiatric Press, Inc., 1990.
Brown GW, Birley JLT, Wing JK: Influence of family life on the course of schizophrenic disorders: A replication.Br J Psychiatry, 112:241–258, 1972.
Vaughn CE, Leff JP: The influences of family and social factors on the course of psychiatric illness.Br J Psychiatry, 129:125–137, 1976.
Haas GL, Glick IR, Clarkin JF, Spence JH, Lewis AB, Peyser J, DeMane N, Good-Ellis M, Harris E, Lestelle V. Inpatient family intervention: A randomized clinical trial. II. Results at hospital discharge.Arch Gen Psychiatry, 45:217–224, 1988.
Glick I, Spencer J, Clarkin J, Haas Gl, Lewis AB, Peyser J, DeMane N, Good-Ellis M, Harris E, Lestelle V: A randomized clinical trial of inpatient family intervention: IV. Follow-up results for subjects with schizophrenia.Schizophr Res, 3:187–200, 1990.
Leff J, Kuipers L, Berkowitz R, Eberlein-Vries R, Sturgeon D: A controlled trial of social intervention in the families of schizophrenic patients.Br J Psychiatry, 141:121–134, 1982.
Leff J, Kuipers L, Berkowitz R, Sturgeon D: A controlled trial of social intervention in the families of schizophrenic patients: Two year follow-up.Br J Psychiatry, 146:594–600, 1985.
Randolph ET, Eth S, Glynn S, Paz GB, Leong GB, Shaner AL, Strachan A, Van Vort W, Escobar J, Liberman RP: Behavioural family management in schizophrenia: Outcome from a clinic-based intervention.Br J Psychiatry, in press.
Tarrier N, Barrowclough C, Vaughn C, Bamrah JS, Porceddu K, Watts D, Freeman H: The community management of schizophrenia: A controlled trial of a behavioral intervention with families to reduce relapse.Br J Psychiatry, 153:532–542, 1988.
Tarrier N, Barrowclough C, Vaughn C, Bamrah JS, Porceddu K, Watts D, Freeman H: Community management of schizophrenia: A two-year follow-up of a behavioral intervention with families.Br J Psychiatry, 154:625–628, 1989.
Falloon IRH, Boyd JL, McGill CW, Razani J, Moss HB, Gilderman AM: Family management in the prevention of exacerbations of schizophrenia.N Eng J Med, 306:1437–1440, 1982.
Falloon IRH, Boyd J, McGill C, Williamson M, Razani J, Moss HG, Gilderman AM, Simpson GM: Family management in the prevention of morbidity of schizophrenia: Clinical outcome of a two-year longitudinal study.Arch Gen Psychiatry, 42:887–896, 1985.
Hogarty GE, Anderson CM, Reiss DJ, Kornblith SJ, Greenwald DP, Javna CD, Madonia MJ: Family psychoeducation, social skills training, and maintenance chemotherapy in the aftercare treatment of schizophrenia: I. One-year effects of a controlled study on relapse and expressed emotion.Arch Gen Psychiatry, 43:633–642, 1986.
Hogarty GE, Anderson CM, Reiss DJ, Kornblith SJ, Greenwald DP, Ulrich RJ, Carter M, and the Environmental-Personal Indicators in the Course of Schizophrenia (EPICS) Research Group: Family psychoeducation, social skills training, and maintenance chemotherapy in the aftercare treatment of schizophrenia. II. Two-year effects of a controlled study on relapse and adjustment.Arch Gen Psychiatry, 48:340–347, 1991.
Leff JP, Berkowitz R, Shavit N, Strachan A, Glass I, Vaughn C: A trial of family therapy versus a relatives' group for schizophrenia.Br J Psychiatry, 154:58–66, 1989.
Leff J, Berkowitz R, Shavit N, Strachan A, Glass I, Vaughn C: A trial of family therapy versus a relatives' group for schizophrenia: Two-year follow-up.Br J Psychiatry, 157:571–577, 1990.
McFarlane WR, Lukens E, Link B, Dushay R, Deakins SA, Dunne EJ, Horen B, Newmark M, Toran J: The multiple family group, psychoeducation and maintenance medication in the treatment of schizophrenia.Arch Gen Psychiatry, In Press.
Zastowny TR, Lehman AF, Cole RE, Kane C: Family management of schizophrenia: A comparison of behavioral and supportive family treatment.Psychiatr Q, 63:159–186, 1992.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schooler, N.R., Keith, S.J., Severe, J.B. et al. Maintenance treatment of schizophrenia: A review of dose reduction and family treatment strategies. Psych Quart 66, 279–292 (1995). https://doi.org/10.1007/BF02238750
Issue Date:
DOI: https://doi.org/10.1007/BF02238750